ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings Inc (CE) (AMBS)

0.0002
0.00
( 0.00% )
Updated: 19:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.0002
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.0401
Market Cap
Previous Close
0.0002
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
123,923
Shares Outstanding
68,272,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.07
Revenue
95k
Net Profit
-4.76M

About Amarantus Bioscience Holdings Inc (CE)

Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative m... Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS' wholly-owned subsidiary Cutanogen Corporation. AMBS' wholly-owned subsidiary MANF Therapeutics, Inc. owns key intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor ("MANF"). MANF Therapeutics, Inc. is developing MANF-based products as treatments for brain and ophthalmic disorders. MANF was discovered by the Company's Chief Scientific Officer John Commissiong, PhD. Dr. Commissiong discovered MANF from AMBS' proprietary discovery engine PhenoGuard. AMBS sold subsidiary Breakthrough Diagnostics to Todos Medical Ltd. in July of 2020. The Company also owns 51% of hemp/CBD company Hempori. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Carson City, Nevada, USA
Founded
-
Amarantus Bioscience Holdings Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker AMBS. The last closing price for Amarantus Bioscience (CE) was $0. Over the last year, Amarantus Bioscience (CE) shares have traded in a share price range of $ 0.000001 to $ 0.0401.

Amarantus Bioscience (CE) currently has 68,272,000 shares outstanding. The market capitalization of Amarantus Bioscience (CE) is $13,654.40 . Amarantus Bioscience (CE) has a price to earnings ratio (PE ratio) of 0.00.

AMBS Latest News

Todos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USA

Full US use of ANDiS 350 extraction systems would increase US daily testing capacity by 25% 3D Med extraction capacity increased by 1,000,000 kits per week Extraction reagent and automation...

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori

Amarantus Acquires Majority Interest in CBD Wellness Company Hempori    Strong customer retention at both stores in Dallas, TX with growing online presence  Focus...

Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's Disease

Amarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease Patent extends patent coverage for eltoprazine to...

Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products

Amarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic Products  Amarantus is receiving Emerald Preferred Stock with a minimum value of...

Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp Industry

Amarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp Industry   New York, NY -- May 28, 2019 -- InvestorsHub NewsWire...

Amarantus Provides 2019 Roadmap

  Amarantus Provides 2019 Roadmap   New York, NY -- January 7, 2019 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

Coeptis Pharma Enters into Agreement to Acquire Elto Pharma

    Coeptis Pharma Enters into Agreement to Acquire Elto Pharma   New York, NY and Wexford, PA -- November 28, 2018 -- InvestorsHub NewsWire -- Coeptis...

Amarantus Provides Corporate Update

  Amarantus Provides Corporate Update   New York, NY -- July 20, 2018 -- InvestorsHub NewsWire -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the...

MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in

  MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in Peer-Reviewed Journal Experimental...

MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model

  MANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal Model New York, NY -- June 11, 2018 -- InvestorsHub NewsWire...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.00020.00020.00026140.0002CS
4-0.0008-800.0010.0011.0E-6793910.00034223CS
120.000199199001.0E-60.04011.0E-61239230.00016409CS
260.00011000.00010.04011.0E-6819510.00015027CS
52-0.00045-69.23076923080.000650.04011.0E-67350370.00092816CS
156-0.0068-97.14285714290.0070.04011.0E-616925840.00372234CS
260-0.0148-98.66666666670.0150.04011.0E-614370580.00597798CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RNVARennova Health Inc (CE)
$ 0.0001
(9,900.00%)
200k
JUVAFJuva Life Inc (CE)
$ 0.0001
(9,900.00%)
1,000
BCCIBaristas Coffee Company Inc (CE)
$ 0.0001
(9,900.00%)
2k
VYGVQVoyager Digital Ltd (CE)
$ 0.0001
(9,900.00%)
2.89k
FBECFBEC Worldwide Inc (CE)
$ 0.0001
(9,900.00%)
1.25M
PPJEPPJ Healthcare Enterprises Inc (PK)
$ 0.000001
(-99.00%)
24.5M
BLSPBlue Sphere Corporation (CE)
$ 0.000001
(-99.00%)
1.17M
HIPHAmerican Premium Water Corporation (PK)
$ 0.000001
(-99.00%)
250
DLAPQDelta Apparel Inc (CE)
$ 0.000001
(-99.00%)
1,000
CMFOChina Marine Food Group Limited (CE)
$ 0.0004
(-98.66%)
2.4k
HCMCHealthier Choices Management Corporation (PK)
$ 0.00005
(0.00%)
63.11M
VTXBVortex Brands Company (PK)
$ 0.0003
(0.00%)
52.47M
PPJEPPJ Healthcare Enterprises Inc (PK)
$ 0.000001
(-99.00%)
24.5M
TKMOTekumo Inc (PK)
$ 0.0002
(0.00%)
20M
RDARRaadr Inc (PK)
$ 0.0009
(5.88%)
12.14M

AMBS Discussion

View Posts
Lolo12 Lolo12 4 weeks ago
CEO S O B garbage will make us rice . What a garbage
🎑 1 🚻 1
lasombra lasombra 4 weeks ago
Unusual volume again today!!
👍️0
Judah137 Judah137 4 weeks ago
What's going on here? Love waking up to a 4,000,000% gain!! Glad I loaded at bottom!!! Hopefully this comes back to life... would think MANF alone would mean buyout for $1.00+ if it keeps showing promising data!!!!
👍️0
JPetroInc JPetroInc 3 months ago
just look what Gerald Commissiong - twice failed, disgraced, flunkey loser AMBS CEO ...

did to his faithful TOMDF shareholders in a mere few years time:

Printing $0.000001 - and now permanently dissolved:



what a pathetic excuse of a disgraced CEO who scammed shareholders in 2 public securities



IMHO, this guy should investigated & in jail

along with his Astoria, Queens, financial mafia co-conspirators...

TOMDF lost $138-Mil. in just under 5 years time - where did all the money go Gerald...?



inquiring minds want to know...!

IMHO, this scam artist will never work on Wall St - ever again...

Managing Partner at Fortitude Advisors

https://app.qwoted.com/companies/fortitude-advisors

can't these guys would have Gerald associated with their name

https://fortitudeadvisors.com/

AJMHO
🥴 1
MattyTrader MattyTrader 3 months ago
Yeah… sickening if this one doesn’t come back.
👍️0
JPetroInc JPetroInc 4 months ago
32 AMBS CEO Blogs by Gerald Commissiong, CEO



and not one blog ever had "any credibility" whats-so-ever to it - just all lies and fabricated realities...!

and they were permanently removed from the internet - what's that tell you...?

http://www.thechairmansblog.com/amarantus-bioscience/blogs/

IMHO, this guy is a fraud and a huckster - always was - always will be...!

AJMHO
🥴 1
JPetroInc JPetroInc 4 months ago
this is a 'DOA' over pumped and faked hype scam stock...!



along with its twice failed, flunky Stanford U. undergrad, disgraced Wall St. indelible stain lying CEO



sorry but that's just the way this stock has been since 2011 inception

AJMHO
🥴 1
Money Management Money Management 4 months ago
Is this Alzheimer’s stock?
👍️0
JPetroInc JPetroInc 4 months ago
the "reality" of all that anyone really needs to know about AMBS and Gerald Commissiong, CEO:



and if you don't get this one, here's another couple more for ya:





SMH - sold his last 2 remaining AMBS shares - lolzzz

MOO lip spiddle & toties
🥴 1
JoeForkeyBolo JoeForkeyBolo 4 months ago
I sold my remaining 2 AMBS shares on Friday. I made a profit on my previous sale of 600K shares, but took a small loss on this sale. 😎

I was only keeping these 2 shares so I could post here as a shareholder and empathize a bit with those with the catastrophic losses on their six-figure investment. The ones who are still posting here and still holding their shares a decade later—clearly an expression of their faith and confidence and continued hope for the ultimate success of their Amarantus Biosciences investment. One has to wonder if they're still having private phone calls with the CEO.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167164997
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168016251
👍️0
JoeForkeyBolo JoeForkeyBolo 4 months ago
It's a good thing you're still holding all of your AMBS shares, as you've posted numerous time. You'll be ready when something develops.

I sold my investment in GC's other company and rolled proceeds into another investment, where I'm already up six figures.

Thanks GC for pointing me in that direction.
👍️0
JPetroInc JPetroInc 5 months ago
dead - simply impossible...!

not with all of these AMBS CEO Blog promised developments in the werks:

Amarantus Bioscience – Chairman’s Blog

http://www.thechairmansblog.com/amarantus-bioscience/blogs/



you mean they were nothing more than Gerald Commissiong's bold-faced lies & self-fabrications...?



SMH folks - twice failed AMBS & TOMDF CEO stooge for the Astoria Queen's financial mafia

they walk away with $-Millions while Gerald the patsy holds the proverbial Wall St indelible stain rep...!



Ask yourself this: was it all really worth scamming the public out of their investment dollars...?

SMH - sad but true

MOO lick spiddles & toties
🥴 1
MattyTrader MattyTrader 5 months ago
Looks dead.
👍️0
JPetroInc JPetroInc 6 months ago
AMBS printing $0.000001

hmm now lets see....43,100 shares sold today x $0.000001 pps = $0.05

somethings brewing - eh ...?



MOO bad karma
👍️ 1 🥴 2
JPetroInc JPetroInc 7 months ago
hows that next project "fruition" looking these daze ...?



MOO pathetic

🤢 1 🥴 1
JPetroInc JPetroInc 7 months ago
lets hear a little chatter out there Gerry...!



MOO oye veh...
🥴 2
JoeForkeyBolo JoeForkeyBolo 7 months ago
Clearly there are issues for you reading a statement and understanding it. You keep highlighting the same text that doesn't answer the question posed.

Where exactly in my post do I say anything about fake IP address, burner phones, or multiple aliases. The only thing mentioned is fake credentials (name and email address) and I stated reason why.

The rest of it you're pulling out of your ASS.

That's it. The last one. You can't provide an accurate or intelligent answer, so you keep throwing the same turd at the wall to see if it will stick. Kinda like how you make investment choices. 💩 💩 💩 None sticking for last 10 years. No zip code change for you.

👍️0
JPetroInc JPetroInc 7 months ago
here you go Joey-the-Forks-Bolo



served up to you ...

just like room service Sporto



uh oh, Gerald's "WeWorks" cubicle ...

must have gotten emptied out in a hurry - eh JOEY...?



but hey, at least you got some toilet paper left

to clean up the mess he left you...!

SMH - can't make this stuff up folks

MOO bad brains
🥴 1
JoeForkeyBolo JoeForkeyBolo 7 months ago
Where exactly in my post do I say anything about fake IP address, burner phones, or multiple aliases. The only thing mentioned is fake credentials (name and email address) and I stated reason why.

The rest of it you're pulling out of your ass. And you have no clue about VPNs and IP addresses. Did your crack IT team at Dominos ever discover who was sending you pizzas? Why haven't you updated us on that?

MiamiMark (whoever the f*ck that is)... how is that relevant? Your new infatuation, perhaps? Kicked GC to the curb? Maybe it was this guy sending the pizzas?

👍️0
JPetroInc JPetroInc 7 months ago
hey JoeyForkitBolos

seems like AMBS & TOMDF has to worry about posters logging into their CC's with fake IP addy's...

burner phones, multiple aliases and phony email's - eh JOEY...?



but hey - who really knows - maybe our buddy MiamiMark can help?



SMH - lolzzz

MOO bad brains
🥴 1
JPetroInc JPetroInc 8 months ago
Man Behind the Buzz

Gerald Commissiong - twice failed Stanford University "Financial Engineer" CEO hack

now looking for your money - so he can do it a 3rd time

my-o-my ... how just a few years can change things on a NY dime

especially when things are built on illusions, deceiving SH's and a Make It Up as We Go Along portfolio



SMH - only in America can you rip people off and get away with it

all that's left are broke AMBS and TOMDF SH's, and an indelible 'stain' on Wall St.

MOO sad
👍️ 1 🥴 1
JPetroInc JPetroInc 8 months ago
how's that "MANF March" doing Gerald...?

Amarantus Bioscience – Chairman’s Blog

http://www.thechairmansblog.com/amarantus-bioscience/blogs/

you know the one - AMBS CEO Blog #29



29.) MANF Begins its March Towards the Clinic
May 14th, 2015 - by Joseph Rubinfeld

Throughout my 50+ years in the biopharmaceutical industry, I have seen many programs with great promise, but very few programs that possess the fundamentally groundbreaking scientific potential to modify disease biology inherent in MANF. In the early days of Amgen, I remember EPO was Number 9 on the priority list for product development. I had to lobby extremely hard to get it moved up the ranks to Number 5 (largely due to the concept of using it in an orphan indication, replacement therapy in kidney dialysis patients). Despite the strong science behind EPO, most people in Amgen’s leadership wanted to focus on some other perceived near term potential opportunities like interlukins, inteferon, chicken growth hormone, malaria, hybridomas, etc. Without this lobbying, I am not certain we would have seen the Amgen we now know today.

I saw a similar situation with Amarantus in 2012. Towards the end of that year when I first began investing in Amarantus, and initially joined the Company as an advisor, I believed that the vast potential of the MANF program could be harnessed into a major medical breakthrough by expanding the focus of preclinical studies beyond Parkinson’s disease, and into a broader area of orphan drugs. In 2013, the Company had its first breakthrough in this area, through some groundbreaking work from the University of Miami’s Bascom Palmer Eye Institute. By demonstrating that MANF had tremendous potential to protect rods and cones in degenerative models of retinitis pigmentosa (RP), we had identified an orphan indication for which no competition existed in the market that would allow the Company to conduct some additional proof of concept work to validate prior to moving MANF into the clinic. Shortly thereafter, we generated data supporting the use of MANF in a broad range of ocular conditions, including orphan conditions such as retinal artery occlusion, as well as large indications such as glaucoma. Taken together, MANF’s potential to treat vision loss associated with a range of ophthalmological conditions alone makes it a compelling product opportunity worthy of further development.

However, we now know full well ophthalmology is just the beginning of the MANF opportunity. Either by internal development, collaboration with academics, or evaluation of the scientific literature, we now know that the MANF program’s potential expands far beyond ophthalmology, and into the areas neurology, otology, cardiology and metabolism (diabetes), among others. This vast potential for MANF is what makes today’s announcement personally so exciting for me, as the initiation of IND-enabling studies (which start with initiation of clinical grade manufacturing) has been the rate-limiting step for true product development value creation for MANF not only for the ophthalmology programs, but also the rest of the MANF pipeline. We have spent the last 12 months evaluating clinical grade material suppliers in parallel with generating the scientific and regulatory framework to support a robust IND-enabling program that will take MANF into the clinic where we can get a first glimpse of MANF’s human efficacy profile. We believe Catalent is the best clinical-grade supplier to support our development, and are extremely pleased that the process is now moving forward. Before this major step forward MANF was a wish, now it is on the path to becoming a reality.

Going forward, we will be formalizing agreements with key constituents including key opinion leaders, patient advocacy groups and regulatory experts in order to drive this program into the clinic and begin to treat patients suffering from the many afflictions MANF may impact. This is where true value will be generated and we are extremely pleased that the process has now begun.

As a Board member, I am very pleased to be helping guide the Company’s strategy forward as we have created a truly de-risked product development pipeline that can create value in many different areas, all the while providing MANF with the necessary infrastructure to be diligently moved forward without the need to rush its development and compromise its true value.

Thank you for your continued interest and support, we look forward to sharing more updates as MANF progresses towards the clinic.

Best,
Joseph Rubinfeld, PhD
Independent Director
Amarantus BioScience Holdings
👍️ 1 🥴 1
JPetroInc JPetroInc 8 months ago
maybe wrong stock board

printing $0.0002



SMH - only more bad news coming

MOO
🥴 1
JPetroInc JPetroInc 8 months ago
dumptin must be out of tune

nothing to see here in AMBS

and definitely nothing to see in the insolvent, liquidated and dissolved TOMDF folks

except JOEY and his ramblin musings



MOO pathetic
🥴 1
lasombra lasombra 8 months ago
BUY VOLUME...
👍️0
JoeForkeyBolo JoeForkeyBolo 8 months ago
Board moderator is back in JAIL. Seems this is a recurring thing.

👍️0
JPetroInc JPetroInc 8 months ago
I don't know velcro...

Fortitude Advisors' still carrying GC as NY managing partner - only thing I can think of is Fortitude maybe doing a toxic deal and may need the exposure to the Astoria Queens financial mafia

either way looks like GC was permanently 'hung out to dry' by TOMDF hierarchy, including JF and the back office admin... which makes sense - those white collar boys make hefty coin on the toxic convertibles and maybe from a few offshore havens

what we do know is TOMDF is 100% dissolved while AMBS is OTC default, dbl. black diamond expert market and non-reporting - might as well be declared BK

AJMHO
🥴 1
velcro velcro 9 months ago
Fortitude Advisors did not need a clown on their staff.
👍️ 1 🤣 1
JPetroInc JPetroInc 9 months ago
glad Fortitude Advisors chose not to sully their reputation

with that of a 2 time looser sham con-artist serial toxic death spiral diluter

and flunky Stanford University “Financial Engineer” fake CEO hack…!

AJMHO
👍️ 1 🥴 1
velcro velcro 9 months ago
Gerald Commission no longer appears on the Fortitude Advisors website www.fortitudeadvisors.com
Obviously he was a negative drag on their credibility.
👍️0
JPetroInc JPetroInc 9 months ago
AMBS TA Chart & CEO Update

AMBS on a run-away southbound out-of-control pps TRAIN WRECK these past few years...!

all under Gerald Commissiong - twice failed public securities CEO hack

and Stanford University "Financial Engineer" patented flunky



got to love the fact that Gerald Commissiong TOMDF terminated CEO has permanently moved on...

from the "DISSOLVED & OUT OF BUSINESS" TOMDF right quick

via the Israeli insolvency judicial system - in only +5 weeks time - Wowza...!

Todos Medical Announces Insolvency Proceedings in Israel
December 22, 2023 17:28 ET

https://www.globenewswire.com/en/news-release/2023/12/22/2800853/0/en/Todos-Medical-Announces-Insolvency-Proceedings-in-Israel.html

and just LOOKIE HERE - now a Managing Partner with Fortitude Advisors in Austin Tx:



even sporting a new PhD - or is that a mistake for PnD...?

if you can believe this folks - here it is - in live and living color no less:



Website
https://fortitudeadvisors.com/

Phone
512-664-2050

well Sham Wow Gerald


what the hell happened to AMBS - Gerry...?



all under your outstanding leadership and watchful CEO and C-Level Executive Suites business prowess...?

you can't even find the Amarantus Bioscience website on Google -

Amerantus Bioscience "Permanently Closed" - WTF did you do Gerry....?



we had 32 AMBS CEO Blog reasons to believe ever single word you put in writing no less - Gerry...!



fortunately for Gerald - the AMBS CEO Blog is no longer on the World Wide Web...!

now just why in hell is that Gerald...?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172750051

or were these just all lies to further a sham with - well you know...

the Astoria Queens financial mafia and back office admin, accountants etc etc etc...?

and least we forget - the social media Pumper Boys...?

Financial Engineering my royal right cheek arse Gerald...!



would you or your family EVER trust this man with your hard earned honest dollars - ever again...?



SMH - twice failed CEO of two (2) public securities AMBS and TOMDF

now onto a "Managing Partner" with an "M&A and Financing Transactions" firm

Yikes - gotts to ask someone at Fortitude Advisors "what's wrong with this picture..."

SMH - can't make this stuff up folks...!

this is worse than a Bad Harlequin Romance Novel...ouy veh Gerry….ouy veh…!

Psalm 23:5: "You prepare a table before me in the presence of my ENEMIES. You anoint my head with oil; my cup overflows. Surely goodness and mercy will follow me all the days of my life, and I will dwell in the house of the LORD forever.…"
You shall not be punished for your sins - but by your sins...!

AJMHO
👍️ 1
JPetroInc JPetroInc 9 months ago
sorry to say - Gerald Commissiong's been a bad man...!

just CLICKIE HERE to see that AMBS's other kissing-cousin scam TOMDF is now totally dissolved - and rightfully so:

https://todosmedical.com/about



***** BANKRUPT - INSOLVENT - LIQUIDATED - DISSOLVED - TERMINATED - OUT OF BUSINESS - CLOSED *****

got to applaud the efforts of TOMDF's Founder & former Dir., Pres. & CEO - Rami Zigdon in shutting the TOLLOVID SCAM down

Todos Medical Announces Insolvency Proceedings in Israel
December 22, 2023
https://finance.yahoo.com/news/todos-medical-announces-insolvency-proceedings-222800017.html

only took the Israeli Judge 6 weeks to put TOMDF scam to "FINAL REST"

and to exemplify Gerald Commissiong as a disgraced, twice failed CEO hack - who'll now be hung out to dry

would you or your family trust this man with your money - ever again...?

aprox. $138-Mil. trhough the TOMDF books in 5 years - what happened to all this money...?

***** INVESTIGATE GERALD COMMISSIONG - TOMDF CEO *****



"You prepare a table before me in the presence of my enemies. You anoint my head with oil; my cup overflows. Surely goodness and mercy will follow me all the days of my life, and I will dwell in the house of the LORD forever.…"

Gerald Commissiong is now an indelible Wall St stain ...

and a permanent disgraced in the public securities world...

SMH - sad but true...!

MOO
👍️ 2
JPetroInc JPetroInc 9 months ago
oh yeah, what's the volume...?

OEM
👍️0
lasombra lasombra 9 months ago
What is our status here? Nice buy today...why? TIA for any info....
👍️ 1
JPetroInc JPetroInc 10 months ago
yo Lolol12

how stoopid can you be - what garbage...!



SMH - dookie in bambam is all you'll get from this ticker and its twice failed CEO hack...!



MOO shite
👍️0
Lolo12 Lolo12 10 months ago
How stupid can you be what a garbage
👍️ 1
JPetroInc JPetroInc 10 months ago
Todos Medical Announces Insolvency Proceedings in Israel
Press Release | 12/22/2023

https://www.wallstreet-online.de/nachricht/17658569-todos-medical-announces-insolvency-proceedings-israel

WOWZA - Tollovid is now "burnt offerings" - simultaneously TOMDF's "books are cooked"

TOMDF will soon be BK, as it teeters on the proverbial edge of unreconcilable insolvency

also with the twice failed Stanford "Financial Engineer" CEO hack Gerald Commissiong being the quintessential "link" between TOMDF and AMBS...

it stands to reason that TOMDF going BK will have a significant adverse impact on AMBS

not to believe so would only enforce ones own folly and inevitable downfall



would you trust this man with your family's hard earned honest money...?

MOO sad
👍️0
Lolo12 Lolo12 11 months ago
$1.00 next year watch,
👍️ 1
MattyTrader MattyTrader 11 months ago
Some action today
👍️ 1
JPetroInc JPetroInc 11 months ago
yeah right - like were going to believe you ...

with your multiple aliases, burner phones, and fake IP addresses...?



ain't that right JOEY - or is it Waprcore - lolzzz...!

so many aliases - so much pumpin to do - your credibility's now permanently shot pal....!



SMH - get back on dem phones...!

MOO tout
👍️0
JPetroInc JPetroInc 11 months ago
couldn't be anymore "right as rain" then that Les

these pumpin stooges work in groups - if you get what I mean:



wink wink...!

MOO pathetic
👍️0
freegriff freegriff 11 months ago
Let's start with a penny. That's 10x from here and realistic in the near term given some of the catalysts re Magna, MANF, and 3CL. That would have the company at a $6.3M market cap. I mean why not? And why not a dime from there if the skies start clearing?
🏁 1 👍️ 2
leslunier leslunier 11 months ago
typical childish answer.
👍️0
JoeForkeyBolo JoeForkeyBolo 11 months ago
About your assumptions...

👍️0
leslunier leslunier 11 months ago
well let me refresh your memory. Wasn't it you that criticized a poster for making a post and not owning any shares? Memory gone Joey? Guess you must have forgotten to take your meds this morning. Since GM posted on this board we assumed he was a shareholder of AMBS. Guess your buddies are OK doing that. And while we are discussing posting on a board without being a share holder I can only assume you still own shares in AMBS. Unless you are still a hypocrite and GC ass kisser.
Don't forget your meds Joey. Wink, wink
👍️0
JoeForkeyBolo JoeForkeyBolo 11 months ago
You're not making any sense. You must have contracted Covid multiple times like JP and it's affecting your ability to think or remember things. GM never invested in AMBS. He did invest in Todos and still owns those shares, as I do. Nothing else in your post makes any sense.

But believe whatever you want. JP can help you with recommendations for 9 specialists for your deteriorating cognitive ability. Don't forget to take your Geritol daily. And your Metamucil for regular bowel movement.
👍️0
leslunier leslunier 11 months ago
one grade ahead of you hypocrite. Guess he must have just sold as his post was resent. See your're still around haven't sold yet Joey?
👍️0
leslunier leslunier 11 months ago
one grade ahead of you hypocrite. Guess he must have just sold as his post was resent. See your're still around haven't sold yet Joey?
👍️0
JoeForkeyBolo JoeForkeyBolo 11 months ago
Had GM ever invested in AMBS, he would at least have been man enough to sell and move on by this point, and not spend a decade crying on a public message board about it. And if he believed the CEO was a scammer, he certainly wouldn't have been dumb enough to invest with him again. That decision was YOURS. You can't blame that on the CEO.

Just the facts, Sherlock!

"Looky here"? What, are you stuck in 6th grade?
👍️0
leslunier leslunier 11 months ago
Well looky here at the hypocrite. Weren't you the one that took posters to task for posting when not being a shareholder? And by the way ABMS still trades shares. Doesn't have to be a shareholder from years ago. Could have bought on your consistent praise of GC. Look in the mirror and ask where your investment is now.
Only positive is AMBS is trading at twice the price of tomdf. What a freekin joke and ambs has no revenue. Let's see how you spin this one.
Just facts sherlock!
👍️0

Your Recent History

Delayed Upgrade Clock